Reckitt Benckiser Group plc (3RB) - Stock & Dividends
Exchange: XETRA Stock Exchange • Country: United Kingdom • Currency: EUR • Type: Common Stock • ISIN: GB00B24CGK77
Reckitt Benckiser Group plc, traded on the XETRA as 3RB, is a global manufacturer and distributor of various health, hygiene, and nutrition products. Their diverse portfolio includes skincare items like acne treatment creams, facial washes, and cleansing pads, along with germ protection products, contraceptives, heartburn remedies, and joint health supplements. Brands such as Clearasil, Dettol, Durex, Gaviscon, Nurofen, Mucinex, Queen V, Strepsils, and Veet are included in their product range.
Furthermore, Reckitt Benckiser offers a wide array of household items, such as fragrances, water softeners, cleaning agents, dishwashing products, toilet cleaners, disinfectants, pest control solutions, stain removers, and fabric care items under labels like Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite. They specialize in maintaining hygiene in various aspects of daily life.
In the realm of wellness, the company also provides essential vitamins, minerals, and dietary supplements under popular brands such as Biofreeze, Airborne, Mead Johnson, Move Free, Enfamil, Neuriva, and Nutramigen, catering to the health-conscious consumer demographic.
Established in 1819 and based in Slough, the United Kingdom, Reckitt Benckiser Group plc continues to expand its product offerings to meet the evolving needs of consumers worldwide. For more information, you can visit their website at https://www.reckitt.com.
Drawdown (Underwater) Chart
3RB Stock Overview
| Market Cap in USD | 36,681m |
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| GiC SubIndustry | Personal Care Products |
| TER | 0.00% |
| IPO / Inception |
3RB Stock Ratings
| Growth 5y | -2.00 |
| Fundamental | 55.6 |
| Dividend | 6.61 |
| Rel. Performance vs Sector | -3.25 |
| Analysts | - |
| Fair Price Momentum | 47.29 EUR |
| Fair Price DCF | 89.13 EUR |
3RB Dividends
| Yield 12m | 4.22% |
| Yield on Cost 5y | 3.58% |
| Dividends CAGR 5y | 1.53% |
| Payout Consistency | 97.7% |
3RB Growth Ratios
| Growth 12m | -27.17% |
| Growth Correlation 12m | -61% |
| Growth Correlation 3m | -50% |
| CAGR 5y | -3.20% |
| Sharpe Ratio 12m | -1.22 |
| Alpha vs SP500 12m | -38.61 |
| Beta vs SP500 5y weekly | 0.28 |
| ValueRay RSI | 81.93 |
| Volatility GJR Garch 1y | 25.03% |
| Price / SMA 50 | -0.23% |
| Price / SMA 200 | -13.35% |
| Current Volume | 10.3k |
| Average Volume 20d | 18.8k |
External Links for 3RB Stock
As of May 09, 2024, the stock is trading at EUR 53.18 with a total of 10,330 shares traded.
Over the past week, the price has changed by +1.33%, over one month by +9.56%, over three months by -19.95% and over the past year by -25.84%.
According to ValueRays Forecast Model, 3RB Reckitt Benckiser Group plc will be worth about 51.4 in May 2025. The stock is currently trading at 53.18. This means that the stock has a potential downside of -3.29%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 51.4 | -3.29 |